Base4 Biotechnology
PrivateMomentum
Top 50%
of companies Caplight tracks
Company Overview
Base4 Biotechnology is a biotechnology company that develops RNA-modulating small molecule drugs using its proprietary DART (Dynamic Atomic-Resolution RNA Targeting) platform.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Base4 Biotechnology Comparables
Compare Base4 Biotechnology with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Serna Bio | 91% | |
| Ribometrix | 88% | |
| RiboNova | 86% | |
Base4 Biotechnology Funding Rounds
Historical fundraising activity
Key People
Founding team and executive leadership
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 17, 2026
Monthly visitors increased 63% MoM.
- Feb 1, 2026
Monthly visitors increased 129% MoM, reaching 4.4K.
Base4 Biotechnology Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Base4 Biotechnology's valuation, stock price, and market status.